Using a web tool (PACT) and patient navigation to improve goals-of-care conversations for hematopoietic cell transplant survivors
Official title: Improving Goals of Care Conversations With Hematopoietic Cell Transplant Survivors (IMPACT - HCT)
Run by Fred Hutchinson Cancer Center · NCT07052630 · Data updated 2026-11-12
This program tries the PACT website, a trained patient navigator, or both to help blood-cancer survivors who had a hematopoietic cell transplant have clearer advance care planning and goals-of-care conversations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | October 21, 2025 |
| Main results expected | February 28, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07052630 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18+) who had a hematopoietic cell transplant for a blood cancer 1–5 years ago, who can read and speak English, have internet access, and have not completed advance directives or had a goals-of-care conversation are ideal candidates.
✕Probably not a fit
People without internet access, non-English speakers, those who already completed advance directives or had goals-of-care conversations, those unable to consent, or those with uncontrolled psychiatric illness are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants who are 1–5 years post-hematopoietic cell transplant are randomized to one of four arms: PACT website plus a 45–60 minute navigation session, navigation only, PACT only, or usual care. The PACT intervention is a four-week, web-based toolkit for advance care planning, and the navigation intervention is a single session with a trained health coach to review goals-of-care and advance directive materials. Study staff collect outcomes related to engagement in advance care planning and occurrence of goals-of-care conversations, with follow-up at 4 and 12 weeks after the intervention period. The trial requires English fluency and internet access and excludes those unable to consent or with uncontrolled psychiatric illness.
Why it matters
Potential benefit: If successful, the interventions could increase completion of advance directives and improve end-of-life care that matches patient preferences for HCT survivors.
How similar studies have gone: Prior work with navigator-led ACP programs and web-based advance care planning tools has shown improved documentation and patient engagement, but combining PACT with navigation specifically in HCT survivors is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Received a transplant for a hematologic malignancy * Current age 18 years of age or older * Currently 1 to 5 years after HCT * Ability to speak and read English * Has not completed all advance directives and/or had a goals of care (GOC) conversation with their physician * Access to the internet (via computer, tablet, or mobile device) Exclusion Criteria: * Unable to provide informed consent * Uncontrolled psychiatric conditions (confirmed through electronic health record \[EHR\] by study staff)
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Megan Shen, PhD — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Megan Shen, PhD
- Email: mshen2@fredhutch.org
- Phone: 206-667-4172
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual informed consent methods help people decide to join cancer research
This trial tests whether virtual human communicators and different consent messages can influence cancer patients’ understanding and willingness to participate in research.
-
AI-powered supportive care chatbot for young adult cancer survivors
A chatbot driven by artificial intelligence is tested to help young adult cancer survivors manage symptoms and care needs after treatment.
-
Telehealth pharmacist-led opioid education for cancer patients
This pilot tests a telehealth group education session led by a palliative care pharmacist to help adults with cancer use opioids more safely and effectively.
-
Mindfulness program to help with symptoms in chronic graft-versus-host disease
A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.
-
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors
This trial tests whether a gentle brain stimulation method (tDCS) can help reduce numbness, tingling, and pain from CIPN in cancer survivors who are not currently in treatment.
-
High Fiber Program to see if more fiber helps patients after an allogeneic stem cell transplant
This program tests whether a high-fiber diet can help adults undergoing allogeneic hematopoietic cell transplant eat more fiber and feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.